SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Morepen Laboratories informs about press release

13 May 2025 Evaluate
Morepen Laboratories has informed that it enclosed a press release with the title ‘Morepen Board Proposed Dividend After 23 Years Scores Highest PAT of ?118 Crore in FY25’.

The above information is a part of company’s filings submitted to BSE.

Morepen Laboratories Share Price

41.25 1.13 (2.82%)
15-Apr-2026 10:44 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1672.35
Dr. Reddys Lab 1217.25
Cipla 1222.60
Zydus Lifesciences 931.00
Lupin 2343.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×